Catherine A. Dennen

Statistical Validation of Risk Alleles in Genetic Addiction Risk Severity (GARS) Test: Early Identification of Risk for Alcohol Use Disorder (AUD) in 74,566 Case–Control Subjects

Kenneth Blum, David Han, Ashim Gupta et al. · Journal of Personalized Medicine · 2022 · 29 citations · Full text

Frequency of the Dopamine Receptor D3 (rs6280) vs. Opioid Receptor µ1 (rs1799971) Polymorphic Risk Alleles in Patients with Opioid Use Disorder: A Preponderance of Dopaminergic Mechanisms?

Marjorie C. Gondré‐Lewis, Igor Elman, Tanya N. Alim et al. · Biomedicines · 2022 · 19 citations · Full text

Dopaminergic Mechanisms, Psychopharmacology, Social Sciences +23

Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?

Kenneth Blum, Catherine A. Dennen, Igor Elman et al. · Journal of Personalized Medicine · 2022 · 19 citations · Full text

Theorizing the Role of Dopaminergic Polymorphic Risk Alleles with Intermittent Explosive Disorder (IED), Violent/Aggressive Behavior and Addiction: Justification of Genetic Addiction Risk Severity (GARS) Testing

Edward J. Modestino, Kenneth Blum, Catherine A. Dennen et al. · Journal of Personalized Medicine · 2022 · 16 citations · Full text

Genetic Addiction Risk and Psychological Profiling Analyses for “Preaddiction” Severity Index

Kenneth Blum, David Han, Abdalla Bowirrat et al. · Journal of Personalized Medicine · 2022 · 15 citations · Full text